Schjesvold, F., & Goldschmidt, H. (2020). Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial. European journal of haematology, 104(5), . https://doi.org/10.1111/ejh.13379
Chicago-Zitierstil (17. Ausg.)Schjesvold, Fredrik, und Hartmut Goldschmidt. "Quality of Life Is Maintained with Ixazomib Maintenance in Post-transplant Newly Diagnosed Multiple Myeloma: The TOURMALINE-MM3 Trial." European Journal of Haematology 104, no. 5 (2020). https://doi.org/10.1111/ejh.13379.
MLA-Zitierstil (9. Ausg.)Schjesvold, Fredrik, und Hartmut Goldschmidt. "Quality of Life Is Maintained with Ixazomib Maintenance in Post-transplant Newly Diagnosed Multiple Myeloma: The TOURMALINE-MM3 Trial." European Journal of Haematology, vol. 104, no. 5, 2020, https://doi.org/10.1111/ejh.13379.